Changes in renal function in patients with atrial fibrillation: Efficacy and safety of the non–vitamin K antagonist oral anticoagulants - 11/04/18

Kazuo Miyazawa, MD ^a, Daniele Pastori, MD ^{a, b}, Gregory Y.H. Lip, MD ^{a, c, ⁎}

^a Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom 

^b Department of Internal Medicine and Medical Specialties, I Clinica Medica, Atherothrombosis Centre, Sapienza University of Rome, Rome, Italy 

^c Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark 

^⁎Reprint requests: Gregory Y. H. Lip, Institute of Cardiovascular Sciences, City Hospital Birmingham Dudley Rd, B18 7QH, England (UK).Institute of Cardiovascular SciencesCity Hospital Birmingham Dudley RdB18 7QHEngland (UK)

Le texte complet de cet article est disponible en PDF.